LLLT remains one of only three FDA-cleared approaches for AGA (alongside minoxidil and finasteride); HairMax has accumulated 8 FDA clearances across its device line. No major new clearance specific to 2025-2026 was identified in this research pass beyond ongoing device iterations.
- Lab
- Phase 1
- Phase 2
- Phase 3
- Approved
Approved (some countries)
How it works
Red/near-infrared light delivered via combs, caps, bands, or in-clinic panels to the scalp, hypothesized to stimulate mitochondrial activity in follicle cells and prolong the growth phase.
Results so far
Evidence base is a mix of device-specific clinical studies submitted for 510(k) clearance; this research pass did not pull a consolidated, dated efficacy figure and instead found general claims of being 'FDA-cleared' from secondary device-marketing-adjacent sources.
What's next
N/A — mature, already-marketed device category.
In India
Not specifically assessed; LLLT devices are sold/imported into India via e-commerce, but Indian-specific regulatory (CDSCO medical device) status was not verified in this research pass.
Sources
- Company announcement ↗ (accessed 2026-10-17)
- Company announcement ↗ (accessed 2026-10-17)
- Trial registry ↗ (accessed 2026-10-17)
What to do today: treatments in development aren't a reason to wait. Ask a dermatologist about the options that work now, such as minoxidil and, for men, finasteride.
Discussion
Share your experience or ask a question. New members' posts are reviewed before they appear.